Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

The Company has made a further investment by acquiring an additional equity stake of 4.07% in KIMS Hospital Enterprises Private Limited, it's subsidiary on November 30th, 2022. Consequently, the Company now holds 90.74% of the total Paid-up Equity Share capital of KIMS Hospital Enterprises Private Limited
01-12-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company is having an Investors call with Canara Robeco Mutual Fund today i.e. 30th November 2022.
30-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Krishna Institute of Medical Sciences Limited ('the Company') has made a further investment by acquiring an additional equity stake of 7.79% in Arunodaya Hospitals Private Limited, its subsidiary on November 28, 2022. Consequently, the Company now holds 65.62% of the total paid-up Equity Share capital of Arunodaya Hospitals Private Limited.
29-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company is having an Investors call with Bajaj Allianz Life Insurance Company Limited organized by Kotak Securities Limited on 24th November 2022.
23-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Please find the enclosed herewith Related Party Transactions of the Company for the half year ended September 30, 2022.
22-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

In Continuation to our letter dated 10th November 2022 the Company organized a conference call with the Investors/ Analysts on Saturday, 12th November 2022 at 10:00 am (IST). A copy of the Transcript of the conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded on the Company''s Website
17-11-2022

Buy Krishna Institute of Medical Sciences; target of Rs 1660: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1660 in its research report dated November 14, 2022.
15-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

the audio recording of the earnings call and earnings presentation made on November 11, 2022, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the Quarter and Half Year ended September 30, 2022, is available on the Company's website at https://www.kimshospitals.com/investors > Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 22-23
12-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

the audio recording of the earnings call and earnings presentation made on November 11, 2022, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the Quarter and Half Year ended September 30, 2022, is available on the Company's website at https://www.kimshospitals.com/investors > Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 22-23
12-11-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of newspaper advertisement of the unaudited standalone and consolidated financial results of the company for the Quarter and Half Year ended 30th September, 2022 published on 11th November, 2022 in Financial Express (English) and Navatelangana (Telugu).
12-11-2022
Next Page
Close

Let's Open Free Demat Account